Ridge Augmentation With Simultaneous Implant Placement Using Bone Blocks With Autogenous Tooth Graft
1 other identifier
interventional
30
1 country
1
Brief Summary
Autogenous bone, with its osteogenic, osteoinductive, and osteo-conductive characteristics has been used for bone grafts with optimal integration into host tissues. For this reason, autogenous bone has been often considered the gold standard of bone regeneration material. However, the amount of autogenous bone that may be harvested is limited, and the harvesting procedure is traumatic. Bone substitutes, including allografts, xenografts, and alloplasts have been used successfully as alternatives to autogenous bone grafts in ridge augmentation procedures. In 2008, autogenous tooth bone graft (ATG) was introduced and used for the first time as a bone grafting material for GBR. The tooth contents are extremely similar to that of the alveolar bone. The enamel inorganic, organic, and water contents are 95 percent, 0.6 percent, and 4 percent, respectively. However, in the dentin, the percentages are 70 to 75 percent, 20 percent, and 10 percent, respectively. They are 65 percent, 25 percent, and 10 percent, respectively, when compared to the alveolar bone content. The aim of this study is to compare ridge augmentation using autogenous bone block (ABB) with immediate implant placement and filling the generated gap with autogenous bone graft (ABG) or ATG, or ridge augmentation using xenograft bone block (XBB) with immediate implant placement and filling the generated gap with ATG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2022
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2023
CompletedDecember 22, 2023
December 1, 2023
1.4 years
April 1, 2022
December 19, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Clinical evaluation probing pocket depth and amount of bone around simultaneously placed dental implants
Changes on pocket depth and amount of bone using ABG or ATG with ABB or XBB around simultaneously placed dental implants
9 months
radiographic outcome measuring the amount of bone around simultaneously placed dental implants
the radiographic outcome by measuring the amount of bone by using ATG or ABG on bone formation with ABB or XBB around simultaneously placed dental implants
9 months
Study Arms (3)
ABB and ATG with simultaneous implant placement
EXPERIMENTALUsing ABB with ATG to fill the gap around simultaneously placed dental implants
XBB and ATG with simultaneous implant placement
EXPERIMENTALUsing XBB with ATG to fill the gap around simultaneously placed dental implants
ABB and ABG with immediate implant
ACTIVE COMPARATORUsing ABB with ABG to fill the gap around immediately placed dental implants
Interventions
Ridge augmentation using ABB and ATG as a graft material with simultaneous implant placement
Ridge augmentation using XBB and ATG as a graft material with simultaneous implant placement
Ridge augmentation using ABB and ABG as a graft material with simultaneous implant placement
Eligibility Criteria
You may qualify if:
- Teeth with buccal bone destruction by periodontal disease and need extraction (horizontal or vertical bone defect);
- Absence of acute inflammation;
- Absence of uncontrolled systemic illness that would preclude implantation;
- Good dental and systemic healthy conditions;
- Patients were willing and able to return for multiple follow-up visits.
You may not qualify if:
- Patients with systemic illnesses,
- psychological abnormalities,
- para-functional habit,
- smokers or alcoholics,
- pregnant and lactating patients,
- patients undergoing or recently completed radiotherapy or chemotherapy,
- patients on drugs affecting the healing process,
- patients with endodontically treated teeth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, Kafrelsheikh University
Kafr ash Shaykh, 33511, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dalia R Issa, PhD
Kafrelsheikh University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
April 1, 2022
First Posted
June 7, 2022
Study Start
April 1, 2022
Primary Completion
August 12, 2023
Study Completion
August 20, 2023
Last Updated
December 22, 2023
Record last verified: 2023-12